News

The new results helped boost Moderna’s stock by more than 4% in early trading Monday, though the company’s shares are still down about 32% for the year. Moderna has more on the science behind mRNA.
The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...
Recent developments that have caused concern include removing all members of a scientific committee that advises the Centers for Disease Control and Prevention (CDC) on vaccines and replacing them ...
Following its acquisition by Supernus Pharmaceuticals, Sage Therapeutics has let go of all of its remaining workforce, which ...
On Independence Day, I will sincerely celebrate a nation that, despite its demagogues and fools, was capable of producing an ...
The partners will use UNP's AI-based macrocycle discovery platform to develop synthetic peptide therapeutics for multiple ...
Professor Hirohide Saito (Department of Life Science Frontiers at CiRA / The University of Tokyo) and Assistant Professor ...
As the head of HHS, Kennedy said his federal department is undergoing an “AI revolution.” He implored viewers to “stop ...
Discover how Professor Shabir Madhi is advancing maternal vaccines to safeguard newborns from RSV, GBS, and more.
The National Association of County and City Health Officials (NACCHO) yesterday released its 2024 Forces of Change Survey ...